Abstract
Background and purpose
Non-steroidal anti-inflammatory drugs are associated with several side effects, such as gastrointestinal mucosal damage, renal toxicity, and cardiovascular side effects. Aiming to find a novel analgesic/anti-inflammatory drug with minimal side effects, the present study was designed to screen and evaluate some newly synthesized pyrazole derivatives.
Method
Anti-inflammatory activity using carrageenan-induced rat paw edema and cotton-pellet-induced granuloma, COX-1/COX-2 selectivity using thin layer chromatography, and analgesic using hot plate and tail flick tests as well as ulcerogenic and renal side effects of the ten compounds were assessed.
Results and discussion
The results of the carrageenan-induced rat paw edema showed that the carboxyphenylhydrazone derivative (N9) was more potent than the chlorophenyl counterpart (N8) with a relative activity compared to celecoxib of 1.08 and −0.13, respectively, after 1 h. Even though this is true, N9 caused significant increase in the ulcer index, creatinine, and Blood Urea Nitrogen levels. The cotton granuloma test showed that the carboxyphenylhydrazone derivative (N7) was also more potent than its chlorophenyl counterpart (N6) with a relative activity compared to celecoxib of 1.13 and 0.86, respectively. Moreover, adding an acetyl not only increased the anti-inflammatory activity from a relative activity compared to celecoxib of 0.57–1.17 for the compounds X4 and N5, respectively, in the granuloma test, but also increased the selectivity toward COX-2 from 0.197 to 47.979.
Conclusion
As a conclusion, from the ten compounds analyzed, N5 and N7 showed promising results as anti-inflammatory/analgesic agents with low ulcerogenicity and nephrotoxicity and thus should be further analyzed to determine the ED50 and other side effects.
Similar content being viewed by others
Abbreviations
- PG:
-
Prostaglandin
- COX:
-
Cyclooxygenase
- NSAIDs:
-
Non-steroidal anti-inflammatory drugs
- X1, X2, X3, X4, N1, N5, N6, N7, N8, N9:
-
Products analyzed
- BUN:
-
Blood urea nitrogen
- SPSS:
-
Statistical Package for the Social Science
References
Abouzeit-Har MS, Verimer T, Long JP (1982) Effect of long term estrogen and lithium treatment on restraint induced gastric erosion in intact and ovariectomized rats. Pharmazie 37(8):593–595
Abu-Ghefreh AA, Masocha W (2010) Enhancement of antinociception by coadminstration of minocycline and a non-steroidal anti-inflammatory drug indomethacin in naïve mice and murine models of LPS-induced thermal hyperalgesia and monoarthritis. Musculoskele Disord 11:276. doi:10.1186/1471-2474-11-276
Ayoub S, Flower R, Seed M (eds) (2010) Cyclooxygenases: methods and protocols. Methods in molecular biology. chapter 8, vol. 644, Springer. doi: 10.1007/978-1-59745-364-6_8
Bailey PJ, Sturm A, Lopez-Ramos B (1981) A biochemical and morphological study of the cotton pellet granuloma in the rat: effects of dexamethasone and indomethacin. Inflammation: mechanisms and treatment. Springer, 4: 345-346. doi: 10.1007/978-94-010-9423-8_50
Bannon AW, Malmberg AB (2007) Models of nociception: hot-plate, tail-flick, and formalin tests in rodents. Curr Protoc Neurosci 10:1002. doi:10.1002/0471142301.ns0809s41
Barkin RL (2012) Topical nonsteroidal anti-inflammatory drugs: the importance of drug, delivery, and theurapeutic outcome. Am J Ther. doi:10.1097/MJT.0b013e3182459abd (Published ahead of print)
Grosser T, Smyth E, FitzGerald GA (2011) Anti-inflammatory, antipyretic and analgesic agents; pharmacotherapy of gout. In: Brunton LL, Chabner BA, Knollmann BC (eds) Goodman & Gilman’s the pharmacological basis of therapeutics, 12th edn. Mc GrawHill, California, Chapter 34. ISBN 978-0-07-162442-8
DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM (2011) Pharmacotherapy: a pathophysiologic approach, 8th edn. Chapter 100, p 102. ISBN 978-0-07-170354-3
Dunn M (1987) The role of arachidonic acid metabolites in renal homeostasis. Drugs 33(1):56–66
Ferguson S, Hebert RL, Laneuville O (1999) NS-398 upregulates constitutive cyclooxygenase-2 expression in the M-1 cortical collecting duct cell line. J Am Soc Nephrol 10(11):2261–2271
Franklin KBJ, Abbott FV (1989) Techniques for assessing the effects of drugs on nociceptive responses. Psychopharmacology 13:145–216. doi:10.1385/0-89603-129-2:145
Guha P, Dey A, Sarkar B, Dhyani MV, Chattopadhyay S, Bandyopadhyay SK (2009) Improved antiulcer and anticancer properties of a trans-resveratrol analog in mice. J Pharmacol Exp Ther. doi:10.1124/jpet.108.145334
Gupta JK, Upmanyu N, Patnaik AK, Mazumder AM (2010) Evaluation of antiulcer activity of leucas lavandulifolia on mucosal lesion in rat. Asian J Pharm Clin Res 3(2):118
Harirforoosh S, Jamali F (2005) Effect of nonsteroidal anti-inflammatory drugs with varying extent of COX-2/COX-1 selectivity on urinary sodium and potassium excretion in the rat. Can J Physiol 94(6):2504–2510. doi:10.1139/y04-129
Le Bars D, Gozariu M, Cadden SW (2001) Animal models of nociception. Pharmacol Rev 53(4):597–652
Jackson LM, Wu KC, Mahida YR, Jenkins D, Hawkey CJ (2000) Cyclooxygenase (COX) 1 and 2 in normal, inflamed, and ulcerated human gastric mucosa. Gut 47(6):762–770. doi:10.1136/gut.47.6.762
Johnsen SP, Larsson H, Tarone RE, McLaughlin JK, Nørgård B, Friis S, Sørensen HT (2005) Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs: a population-based case-control study. Arch Intern Med 165:978. doi:10.1001/archinte.165.9.978
Khan KN, Paulson SK, Verburg KM, Lefkowith JB, Maziasz TJ (2002) Pharmacology of cyclooxygenase-2 inhibition in the kidney. Kidney Int 61:1209–1210
Kumar V, Abbas AK, Fausto N, Aster JC (2010) Acute and chronic inflammation. In: Robbins, Cotrans (eds) Pathologic basis of disease. 8th ed. Saunders, Elservier Inc, Chapter 2: 43–78. ISBN 978-1416031215
Laudanno OM, Esnarriaga JM, Cesolari JA, Maglione CB, Aramberry LJ, Sambrano JS et al (2000) Celecoxib versus indomethacin and gastric lesions in rats. Medicina 60(2):221–224
Lerma EV (2012) Blood urea nitrogen (BUN). http://emedicine.medscape.com/article/2073979-overview
Maddila S, Sampath SGCH, Lavanya P (2012) Synthesis and anti-inflammatory activity of some new 1,3,4-thiadiazoles containing pyrazole and pyrrole nucleus. J Saudi Chem Soc. doi:10.1016/j.jscs.2012.11.007
Mohy El-Din MM, Senbel AM, Bistawroos AA, El-Mallah AA, Nour El-Din NA, Bekhit AA et al (2010) A novel COX-2 inhibitor pyrazole derivative proven effective as an anti-inflammatory and analgesic drug. Basic Clin Pharmacol Toxicol 108:263–273. doi:10.1111/j.1742-7843.2010.00648.x
Schnellmann RG (2001) Toxic responses of the kidney. In: Klaassen CD (ed) Casarett, Doull’s Toxicology: the basic science of poisons, chap 14, 6th edn. McGraw Hill, pp 491–514
Szallasi A, Bíró T (eds) (2012) TRP channels in drug discovery. Methods in pharmacology and toxicology, vol 2, chapter 25. ISBN 978-1-62703-095-3
Tan PV, Nditafon NG, Yewah MP, Dimo T, Ayafor FJ (1996) Eremomastax speciosa: effects of leaf aqueous extract on ulcer formation and gastric secretion in rats. J Ethnopharmacol 54:139–142
Tassorelli C, Greco R, Sandrini G, Nappi G (2003) Central components of the analgesic/antihyperalgesic effect of nimesulide: studies in animal models of pain and hyperalgesia. Drugs 63(1):9–22
Thore SN, Gupta SV, Baheti KG (2012) Novel ethyl-5-amino-3-methylthio-1H-pyrazole-4-carboxylates: synthesis and pharmacological activity. J Saudi Chem Soc 06 (011). ahead of print
Toby L, Derek AW, Derek WG (2002) Anti-inflammatory lipid mediators and insights into the resolution of inflammation. Nat Rev Immunol 2:787–795
Vane J, Botting R (1987) Inflammation and the mechanism of action of anti-inflammatory drugs. FASEB J 1(2):89–96
Vittalrao AM, Shanbhag T, Bairy MK, Shenoy S (2011) Evaluation of antiinflammatory and analgesic activities of alcoholic extract of kaempferia galanga in rats. Indian J Physiol Pharmacol 55(1):13–24
Vogel HG (2008) Drug discovery and evaluation: pharmacologic assays, 3rd ed. Springer
Wakitani K, Nanayama T, Masaki M, Matsushita M (1998) Profile of JTE-522 as a human cyclooxygenase-2 inhibitor. Jpn J Pharmacol 78(3):365–371. doi:10.1254/jjp.78.365
Wallace JL, McKnight W, Reuter BK, Vergnolle N (2000) NSAID-induced gastric damage in rats: requirement for inhibition of both cyclooxygenase 1 and 2. Gastroenterology 119(3):706–714. doi:10.1053/gast.2000.16510
Whelton A (1999) Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications. Am J Med 106:13S. doi:10.1016/S0002-9343(99)00113-8
Whelton A, Hamilton CW (1991) Nonsteroidal anti-inflammatory drugs: effect on kidney function. J Clin Pharmacol 31(7):588–598. doi:10.1002/j.1552-4604.1991.tb03743.x
Whiteley PE, Dalrymple SA (1998) Models of inflammation: measuring gastrointestinal ulceration in the rat. Curr Protoc Pharmacol, 10.2.1–10.2.4. doi: 10.1002/0471141755.ph1002s00
Winyard PG, Morris CJ (2003) Carrageenan-Induced Edema in the Rat and Mouse. In: Winyard PG, Willoughby DA (eds) Methods in Molecular Biology: Inflammation Protocols, vol 225. Humana Press, New Jersey, p 115. ISBN 0-89603-970-6
Xie W (2010) Assessment of pain in animals. Animal models of pain. Springer Protoc 49:1–21. doi:10.1007/978-1-60761-880-5_1
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors state no conflict of interest.
Rights and permissions
About this article
Cite this article
Domiati, S., El-Mallah, A., Ghoneim, A. et al. Evaluation of anti-inflammatory, analgesic activities, and side effects of some pyrazole derivatives. Inflammopharmacol 24, 163–172 (2016). https://doi.org/10.1007/s10787-016-0270-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10787-016-0270-7